Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-12.00	5.87	6.67
Graham Fair Price	inf	0.00	20.96
PEG	inf	0.00	0.04
Price/Book	inf	0.00	1.17
Price/Cash Flow	inf	0.00	13.01
Prices/Earnings	inf	0.00	3.79
Price/Sales	inf	0.00	0.75
Price/FCF	inf	0.00	13.01
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	-39.57	-0.01	0.02
Operating Margin	-94.97	< 0.005	0.08
ROA	-74.83	< 0.005	0.02
ROE	0.08	-0.02	-74.13
ROIC	0.07	-0.01	-84.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.13	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.80	0.00	inf
EPS QOQ	1.02	0.00	inf
FCF QOQ	0.73	0.00	inf
Revenue QOQ	1.00	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	19.60	17.38	-11.33
Days Sales Outstanding (DSO)	61.91	63.75	2.97
Inventory Turnover	4.59	5.18	12.78
Debt/Capitalization	0.40	0.36	-10.07
Quick Ratio	1.44	1.36	-5.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	15.91	0.00	inf
Cash	6.20	0.00	inf
Capex	0.09	0.00	inf
Free Cash Flow	1.43	0.00	inf
Revenue	24.76	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	1.68	1.59	-5.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.79	5.87	228.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating